Home
»
Daily News
Jan.
3 - Large And Growing Public Health Problem Identified: The
Prevalence And Impact Of Arthritis And Other Rheumatic Conditions
Arthritis is the most common cause of disability in the United
States. Over the next 25 years as the Baby Boom generation
continues to age, the toll of this disease will escalate.
To have a clear picture of the looming disease burden and
its impact on our nation's health care and public health systems,
estimating disease prevalence - the number of people affected
by any form of arthritis - is critical.
The National Arthritis Data Workgroup was formed to provide
a single source of national data on various rheumatic conditions.
Supported by the National Institutes of Health, the Centers
for Disease Control, the American College of Rheumatology,
and the Arthritis Foundation, its epidemiology experts use
the best studies available to determine disease prevalence,
assess potential disease impact, and identify gaps in our
understanding of disease rates, populations, and social implications.
In the January 2008 issue of Arthritis & Rheumatism,
the group presents its latest report on the troubling state
of arthritis in America.
Based on analyses of population estimates from the Census
Bureau, responses from national surveys, and findings from
scores of community-based studies across the country, the
National Arthritis Data Workgroup offers an unsettling snapshot
of the 2005 (and future) burden of arthritis. Some key findings
of the study include:
* Overall arthritis: More than 21% of U.S. adults
- over 46 million people - have arthritis or other rheumatic
condition diagnosed by a doctor. Nearly two-thirds of arthritis
patients are younger than 65. More than 60% are women.
Disease rates are similar for whites and African-Americans
and higher than the rates for Hispanics. By 2030, the number
of people with arthritis is projected to increase to nearly
67 million - an increase of 40%.
* Osteoarthritis (OA): Nearly 27 million Americans suffer
from OA, the most common type of arthritis, an increase from
the 21 million estimated in 1990. Rising with age, OA prevalence
also affects the hands and knees of women more frequently
than men and of African Americans more frequently than whites.
* Rheumatoid Arthritis (RA): This confounding and destructive
inflammatory disease affects 1.3 million adults, down from
the 1990 estimate of 2.1 million - in part due to more restrictive
classification criteria but also because of a real drop in
prevalence . Trends show that the average age of diagnosis
has increased steadily over time, suggesting that RA is becoming
a disease of older adults.
* Gout: In 2005 roughly 3 million Americans had gout in the
previous 12 months, up from the estimate of 2.1 million in
1990. An inflammatory arthritis linked to elevated uric acid
in the blood, gout tends to be most prevalent among older
men and more prevalent in older African American males than
in older white or Hispanic males.
* Juvenile Arthritis: Based on recent data from pediatric
ambulatory care visits, an estimated 294,000 children between
the ages of infancy and 17 are affected by arthritis or other
rheumatic conditions.
* The report also includes 2005 prevalence estimates for
fibromyalgia, spondylarthritides, systemic lupus erythematosus,
systemic sclerosis, Sjögren's syndrome, carpal tunnel
syndrome, polymyalgia rheumatic/giant cell arteritis, and
back and neck pain.
"Measuring the prevalence of arthritis poses many challenges,"
acknowledges National Arthritis Data Workgroup spokesperson
and member, Dr. Charles G. Helmick. For starters, some conditions
are episodic and others have no standard case definition.
In addition, estimates for some rheumatic conditions rely
on small or older studies with results that might not apply
to the current U.S. population. However, this report calls
attention to the high prevalence of arthritis nationwide and
the growing burden on not only our health care and public
health systems, but also on American industry and society.
Source: Wiley-Blackwell
(View
the Daily News Archive)
|